OTOF gene
3 stories
-
healthFDA Approves Groundbreaking Gene Therapy for Genetic Hearing Loss
The FDA has approved Otarmeni, the first gene therapy to treat severe to profound hearing loss linked to the OTOF gene, offering new hope for patients.
-
healthFDA Approves First Gene Therapy for Inherited Deafness
Regeneron's Otarmeni receives FDA approval, marking a significant advancement in treating OTOF gene-related hearing loss in children and adults.
-
healthGene Therapy Breakthrough Restores Hearing in 90% of Inherited Deafness Patients
Largest trial of its kind shows experimental gene therapy significantly improves hearing in individuals with congenital deafness, offering new hope beyond cochlear implants.